Predictive biomarkers of survival after neoadjuvant chemotherapy for breast cancer

被引：0
|
作者：
Galvez-Nino, Marco [1 ]
Roque, Katia [1 ]
Angel Bernabe, Luis [1 ]
Castillo, Miluska [1 ]
Sanchez, Joselyn [1 ]
Landa Baella, Maria [1 ]
Calderon, Gabriela [1 ]
De la Cruz, Miguel [1 ]
Dunstan, Jorge [1 ]
Abugatas, Julio [1 ]
Cotrina, Jose [1 ]
Castaneda, Carlos [1 ]
Gomez, Henry [1 ]
机构：
[1] Inst Nacl Enfermedades Neoplas, Lima, Peru
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
Breast cancer; Neoadjuvant; Residual cancer burden; TILs; progression-free survival;
D O I：
10.1158/1538-7445.SABCS19-P1-10-22
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-10-22
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effect of time to breast cancer surgery after neoadjuvant chemotherapy on survival outcomes
    Mahmoud Al-Masri
    Basim Aljalabneh
    Hani Al-Najjar
    Tamador Al-Shamaileh
    Breast Cancer Research and Treatment, 2021, 186 : 7 - 13
  • [22] Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy
    Liu, Ying L.
    Saraf, Anurag
    Lee, Shing M.
    Zhong, Xiaobo
    Hibshoosh, Hanina
    Kalinsky, Kevin
    Connolly, Eileen P.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (03) : 555 - 564
  • [23] In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
    Ladoire, Sylvain
    Mignot, Gregoire
    Dabakuyo, Sandrine
    Arnould, Laurent
    Apetoh, Lionel
    Rebe, Cedric
    Coudert, Bruno
    Martin, Francois
    Bizollon, Marie Helene
    Vanoli, Andre
    Coutant, Charles
    Fumoleau, Pierre
    Bonnetain, Franck
    Ghiringhelli, Francois
    JOURNAL OF PATHOLOGY, 2011, 224 (03): : 389 - 400
  • [24] Effect of time to breast cancer surgery after neoadjuvant chemotherapy on survival outcomes
    Al-Masri, Mahmoud
    Aljalabneh, Basim
    Al-Najjar, Hani
    Al-Shamaileh, Tamador
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (01) : 7 - 13
  • [25] Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy
    Ying L. Liu
    Anurag Saraf
    Shing M. Lee
    Xiaobo Zhong
    Hanina Hibshoosh
    Kevin Kalinsky
    Eileen P. Connolly
    Breast Cancer Research and Treatment, 2016, 157 : 555 - 564
  • [26] In Situ Immune Response after Neoadjuvant Chemotherapy for Breast Cancer Predicts Survival
    Ladoire, S.
    Coudert, B.
    Fumoleau, P.
    Arnould, L.
    Ghiringhelli, F.
    CANCER RESEARCH, 2010, 70
  • [27] Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer
    Haussmann, Jan
    Budach, Wilfried
    Nestle-Kraemling, Carolin
    Wollandt, Sylvia
    Tamaskovics, Balint
    Corradini, Stefanie
    Boelke, Edwin
    Krug, David
    Fehm, Tanja
    Ruckhaeberle, Eugen
    Audretsch, Werner
    Jazmati, Danny
    Matuschek, Christiane
    CANCERS, 2022, 14 (16)
  • [28] Pathological complete response: A predictive survival factor after neoadjuvant chemotherapy in lung cancer
    Milleron, Bernard
    Westeel, Virginie
    Gounant, Valerie
    Wislez, Marie
    Quoix, Elisabeth
    BULLETIN DU CANCER, 2016, 103 (01) : 66 - 72
  • [29] Predictive Factors of Complete Axillary Downstaging after Neoadjuvant Chemotherapy in Breast Cancer Patients
    Vidal, M.
    Perez-Garcia, J. M.
    Munoz, E.
    Saura, C.
    de Mattos, L.
    Gomez, P.
    Cortes, J.
    Baselga, J.
    Bellet, M.
    CANCER RESEARCH, 2010, 70
  • [30] Breast Cancer: Prognosis after neoadjuvant Chemotherapy
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2018, 78 (07)
12345